Regeneron Pharmaceuticals (REGN) Operating Margin (QoQ) (2009 - 2026)

Regeneron Pharmaceuticals (REGN) Operating Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -482.00
Dec 31, 2025 -470.00
Sep 30, 2025 -202.00
Jun 30, 2025 983.00
Mar 31, 2025 -660.00
Dec 31, 2024 -557.00
Sep 30, 2024 155.00
Jun 30, 2024 626.00
Mar 31, 2024 -444.00
Dec 31, 2023 -471.00
Sep 30, 2023 85.00
Jun 30, 2023 225.00
Mar 31, 2023 -111,686.00
Dec 31, 2022 110,512.00
Sep 30, 2022 283.00
Jun 30, 2022 -247,815.00
Mar 31, 2022 246,369.00
Dec 31, 2021 -19.00
Sep 30, 2021 -1,164.00
Jun 30, 2021 2,114.00